1 | Additional Representation Sheet | 28 Jun 2006 |
1 | Examination Report | 28 Jun 2006 |
1 | Journal Copy | 28 Jun 2006 |
2 | Additional Representation Sheet | 28 Jun 2006 |
2 | Certificate | 28 Jun 2006 |
2 | Examination Report | 28 Jun 2006 |
3 | Additional Representation Sheet | 28 Jun 2006 |
3 | Certificate | 28 Jun 2006 |
3 | Examination Report | 28 Jun 2006 |
4 | Journal Copy | 28 Jun 2006 |
4 | Note Sheet | 28 Jun 2006 |
4 | TM-1 | 28 Jun 2006 |
5 | Journal Copy | 28 Jun 2006 |
5 | Note Sheet | 28 Jun 2006 |
5 | Other Documents | 28 Jun 2006 |
6 | Note Sheet | 28 Jun 2006 |
6 | Other Documents | 28 Jun 2006 |
6 | TM-1 | 28 Jun 2006 |
7 | Certificate | 28 Jun 2006 |
7 | Other Documents | 28 Jun 2006 |
7 | TM-1 | 28 Jun 2006 |
8 | TM-12 | 24 May 2016 |
1 | O3 NOTICE | 3386328 | 1785442 | 31 Mar 2016 |
2 | RENEWAL INTIMATION LETTER | 3646567 | 13 Jun 2016 |
Trademark was applied on 28 June 2006 with IP India.
Proprietor of Mefomin is MACLEODS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Mefomin is Registered.
Application number alloted to the trademark is 1465331.
Trademark has been filed in the following category:
WORD